Biggest News Aggregation in the World
📰 Jack Anders News

Jack Anders News Today

Fast, Ad-Free News Updates

Stay updated with breaking news from Jack Anders. Real-time updates on events, politics, business and more.

Bellevue Group AG Boosts Stock Holdings in Revolution Medicines, Inc. (NASDAQ:RVMD)

Bellevue Group AG boosted its position in Revolution Medicines, Inc. (NASDAQ:RVMD – Free Report) by 7.8% during the 4th quarter, according to the company in its most recent disclosure with the Securities and Exchange Commission. The fund owned 5,091,000 shares of the company’s stock after purchasing an additional 369,500 shares during the period. Revolution Medicines […]
Jack Anders Raymond James Jeff Cislini Piper Sandler Bellevue Group Revolution Medicines Inc
Source: wkrb13.com

Bain Capital Life Sciences Investors LLC Takes $31.90 Million Position in Revolution Medicines, Inc. (NASDAQ:RVMD)

Bain Capital Life Sciences Investors LLC bought a new stake in Revolution Medicines, Inc. (NASDAQ:RVMD – Free Report) in the 4th quarter, according to its most recent filing with the Securities and Exchange Commission. The firm bought 1,112,396 shares of the company’s stock, valued at approximately $31,904,000. Revolution Medicines comprises 3.1% of Bain Capital Life […]
Jack Anders Piper Sandler Sushil Patel Securities Exchange Commission Rafferty Asset Management Needham Company

Bain Capital Life Sciences Investors LLC Takes Position in Revolution Medicines, Inc. (NASDAQ:RVMD)

Bain Capital Life Sciences Investors LLC bought a new stake in shares of Revolution Medicines, Inc. (NASDAQ:RVMD – Free Report) during the 4th quarter, according to its most recent filing with the SEC. The firm bought 1,112,396 shares of the company’s stock, valued at approximately $31,904,000. Revolution Medicines accounts for 3.1% of Bain Capital Life […]
Jack Anders Piper Sandler Raymond James Jeff Cislini Clear Harbor Asset Management Securities Exchange Commission
Source: wkrb13.com

Revolution Medicines (NASDAQ:RVMD) Sets New 52-Week High at $40.63

Revolution Medicines, Inc. (NASDAQ:RVMD – Get Free Report) reached a new 52-week high during trading on Wednesday . The company traded as high as $40.63 and last traded at $40.05, with a volume of 295845 shares trading hands. The stock had previously closed at $39.66. Analyst Upgrades and Downgrades Several research analysts have issued reports […]
United States Raymond James Jack Anders Jeff Cislini Piper Sandler Needham Company

Stay Updated with Latest News

Get breaking news updates delivered to your inbox

Browse All News →

Insider Selling: Revolution Medicines, Inc. (NASDAQ:RVMD) CFO Sells $400,300.00 in Stock

Revolution Medicines, Inc. (NASDAQ:RVMD – Get Free Report) CFO Jack Anders sold 10,000 shares of Revolution Medicines stock in a transaction that occurred on Friday, May 3rd. The stock was sold at an average price of $40.03, for a total value of $400,300.00. Following the completion of the transaction, the chief financial officer now directly […]
Jack Anders Raymond James Piper Sandler Zurcher Kantonalbank Zurich Cantonalbank Td Asset Management Inc York Mellon Corp

Revolution Medicines (RVMD) Scheduled to Post Earnings on Wednesday

Revolution Medicines (NASDAQ:RVMD – Get Free Report) will be issuing its quarterly earnings data after the market closes on Wednesday, May 8th. Analysts expect the company to announce earnings of ($0.75) per share for the quarter. Persons that are interested in registering for the company’s earnings conference call can do so using this link. Revolution […]
Piper Sandler Raymond James Jack Anders Jeff Cislini Needham Company Revolution Medicines Inc
Source: wkrb13.com

Revolution Medicines (NASDAQ:RVMD) PT Raised to $45.00

Revolution Medicines (NASDAQ:RVMD – Get Free Report) had its target price upped by Oppenheimer from $43.00 to $45.00 in a research report issued to clients and investors on Friday, Benzinga reports. The firm presently has an “outperform” rating on the stock. Oppenheimer’s price target points to a potential upside of 20.29% from the company’s current […]
Hong Kong United States Raymond James Jack Anders Piper Sandler Margareta Horn

Revolution Medicines (NASDAQ:RVMD) Upgraded to "Strong-Buy" at Raymond James

Revolution Medicines (NASDAQ:RVMD – Get Free Report) was upgraded by equities research analysts at Raymond James from an “outperform” rating to a “strong-buy” rating in a note issued to investors on Wednesday, MarketBeat reports. The brokerage presently has a $48.00 target price on the stock, up from their prior target price of $36.00. Raymond James’ […]
United States New Zealand General New Zealand Piper Sandler Stephen Michael Kelsey Jack Anders

Revolution Medicines, Inc. (NASDAQ:RVMD) Given Average Rating of "Buy" by Brokerages

Revolution Medicines, Inc. (NASDAQ:RVMD – Get Free Report) has received a consensus rating of “Buy” from the ten research firms that are covering the company, Marketbeat reports. Ten analysts have rated the stock with a buy rating. The average 1-year price objective among brokerages that have issued a report on the stock in the last […]
New Zealand General New Zealand United States Jack Anders Piper Sandler Margareta Horn

Explore More Categories

World News India News Business Technology Sports Entertainment Health Science